story of the week
Mirabegron vs Solifenacin in MS Patients With Overactive Bladder Symptoms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mirabegron Versus Solifenacin in Multiple Sclerosis Patients With Overactive Bladder Symptoms: A Prospective Comparative Nonrandomized Study
Urology 2020 Aug 19;[EPub Ahead of Print], BM Brucker, D Jericevic, T Rude, E Enemchukwu, D Pape, N Rosenblum, ER Charlson, L Zhovtis-Ryerson, J Howard, L Krupp, B PeyronnetFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.